NI201100115A - Derivados de morfina - 6 - glucuronido, su preparación y su aplicación en terapéutica. - Google Patents

Derivados de morfina - 6 - glucuronido, su preparación y su aplicación en terapéutica.

Info

Publication number
NI201100115A
NI201100115A NI201100115A NI201100115A NI201100115A NI 201100115 A NI201100115 A NI 201100115A NI 201100115 A NI201100115 A NI 201100115A NI 201100115 A NI201100115 A NI 201100115A NI 201100115 A NI201100115 A NI 201100115A
Authority
NI
Nicaragua
Prior art keywords
morphine
therapeutics
application
alkyl
aryl
Prior art date
Application number
NI201100115A
Other languages
English (en)
Inventor
Dlubala Alain
Ripoche Isabelle
Trecant Claire
Original Assignee
Aplicaciones Terapeuticas En El Dominio Cardiovascular De Derivados
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aplicaciones Terapeuticas En El Dominio Cardiovascular De Derivados filed Critical Aplicaciones Terapeuticas En El Dominio Cardiovascular De Derivados
Publication of NI201100115A publication Critical patent/NI201100115A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/06—Heterocyclic radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invención se refiere a derivados de morfina-6-glucurónido de fórmula (I) siguiente en la que R1 es un grupo heteroaromático de 5 eslabones eventualmente sustituido con uno o varios sustituyentes elegidos entre átomos de halógeno y los grupos alquilo(C1-C4), halógeno, hidroxilo, haloalquilo(C1-C4), haloalquiloxi(C1-C4), alquiloxi(C1-C4), aril-alquilo(C1-C4) y arilo, estando dicho grupo arilo eventualmente sustituido con uno o varios grupos elegidos entre los grupos alquilo(C1-C4), haloalquilo(C1-C4), hidroxilo y alquiloxi(C1-C4), en forma de base o de sal de adición a un ácido así como en el estado de hidrato o de solvato. La presente invención tiene también por objeto su procedimiento de preparación y su aplicación en terapéutica.
NI201100115A 2008-12-10 2011-06-08 Derivados de morfina - 6 - glucuronido, su preparación y su aplicación en terapéutica. NI201100115A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0806949A FR2939437B1 (fr) 2008-12-10 2008-12-10 Derives de morphine-6-glucuronide, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
NI201100115A true NI201100115A (es) 2011-12-14

Family

ID=41031604

Family Applications (1)

Application Number Title Priority Date Filing Date
NI201100115A NI201100115A (es) 2008-12-10 2011-06-08 Derivados de morfina - 6 - glucuronido, su preparación y su aplicación en terapéutica.

Country Status (30)

Country Link
US (1) US8461122B2 (es)
EP (1) EP2376512B1 (es)
JP (1) JP5616356B2 (es)
KR (1) KR20110104486A (es)
CN (1) CN102317301B (es)
AR (1) AR074514A1 (es)
AU (1) AU2009326909B2 (es)
BR (1) BRPI0922733A2 (es)
CA (1) CA2746429A1 (es)
CL (1) CL2011001399A1 (es)
CR (1) CR20110306A (es)
EA (1) EA019053B1 (es)
EC (1) ECSP11011110A (es)
ES (1) ES2468990T3 (es)
FR (1) FR2939437B1 (es)
HK (1) HK1163110A1 (es)
HN (1) HN2011001601A (es)
IL (1) IL213381A (es)
MA (1) MA32952B1 (es)
MX (1) MX2011006252A (es)
MY (1) MY152978A (es)
NI (1) NI201100115A (es)
NZ (1) NZ593344A (es)
PE (1) PE20120260A1 (es)
SG (1) SG172068A1 (es)
TN (1) TN2011000266A1 (es)
TW (1) TW201026312A (es)
UA (1) UA104302C2 (es)
WO (1) WO2010067010A2 (es)
ZA (1) ZA201104305B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103421063B (zh) * 2012-05-23 2016-04-06 宜昌人福药业有限责任公司 一种合成吗啡-6-β-D-葡萄糖醛酸苷的方法
CN111346104B (zh) * 2018-12-21 2022-06-10 宜昌人福药业有限责任公司 一种吗啡-6-葡萄糖醛酸苷透皮给药的药物组合物及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3766188A (en) 1971-06-28 1973-10-16 Yamanouchi Pharma Co Ltd Carbonyldioxymorphinan derivatives
GB9116909D0 (en) 1991-08-06 1991-09-18 Salford Ultrafine Chem & Res Morphine derivatives
GB2282758A (en) 1993-08-23 1995-04-19 Euro Celtique Sa Oral morphine-6-glucuronide compositions
ES2201482T3 (es) * 1997-04-14 2004-03-16 Ufc Limited Derivados de la morfina.
HUP0102333A3 (en) 1998-06-06 2003-07-28 Cenes Ltd Cambridge Morphine-6-glucuronide synthesis
GB0218811D0 (en) * 2002-08-14 2002-09-18 Cenes Ltd Salts of morphine-6-glucuronide
FR2864082B1 (fr) * 2003-12-22 2006-03-10 Synt Em Nouveau derive de la morphine-6-glucuronide, composition pharmaceutique le contenant et son utilisation pour le traitement de la douleur
EP1758452B1 (en) * 2004-05-28 2017-01-25 Human Biomolecular Research Institute Metabolically stable analgesics and pain medications
FR2907121B1 (fr) * 2006-10-12 2012-05-04 Neorphys Nouveaux derives morphiniques

Also Published As

Publication number Publication date
PE20120260A1 (es) 2012-04-13
JP2012511553A (ja) 2012-05-24
SG172068A1 (en) 2011-07-28
UA104302C2 (ru) 2014-01-27
IL213381A (en) 2014-02-27
HK1163110A1 (en) 2012-09-07
EA201170792A1 (ru) 2012-01-30
FR2939437B1 (fr) 2010-12-17
NZ593344A (en) 2013-08-30
WO2010067010A3 (fr) 2011-06-30
MA32952B1 (fr) 2012-01-02
WO2010067010A2 (fr) 2010-06-17
CN102317301B (zh) 2015-08-26
EA019053B1 (ru) 2013-12-30
TW201026312A (en) 2010-07-16
TN2011000266A1 (fr) 2012-12-17
CN102317301A (zh) 2012-01-11
MX2011006252A (es) 2011-11-04
CR20110306A (es) 2011-09-21
ZA201104305B (en) 2012-10-31
EP2376512B1 (fr) 2014-02-26
IL213381A0 (en) 2011-07-31
US20110301107A1 (en) 2011-12-08
AU2009326909B2 (en) 2016-05-26
JP5616356B2 (ja) 2014-10-29
EP2376512A2 (fr) 2011-10-19
MY152978A (en) 2014-12-15
ES2468990T3 (es) 2014-06-17
KR20110104486A (ko) 2011-09-22
ECSP11011110A (es) 2011-07-29
AR074514A1 (es) 2011-01-19
CL2011001399A1 (es) 2011-10-28
US8461122B2 (en) 2013-06-11
FR2939437A1 (fr) 2010-06-11
AU2009326909A1 (en) 2011-06-30
BRPI0922733A2 (pt) 2016-01-05
HN2011001601A (es) 2013-09-16
CA2746429A1 (fr) 2010-06-17

Similar Documents

Publication Publication Date Title
MX2018016267A (es) Metodo para producir derivado de piridona policiclica sustituida y cristal del mismo.
AR111811A2 (es) Compuestos derivados de 1,2,4-oxadiazol y composiciones para el control de nematodos
ES2653419T3 (es) Pirazolopirimidinilamino-indazoles sustituidos
CR10643A (es) DERIVADOS DE 2-ARIL-6-FENIL-IMIDAZOL[1,2-a]PIRIDINAS, SU PREPARACION Y SU APLICACION EN TERAPEUTICA
DOP2007000014A (es) Derivados de sulfonamidas, su preparacion y su aplicacion en terapeutica
CO6251235A2 (es) Compuestos derivados de azetidinas su preparacion y su aplicacion en terapeutica
DOP2010000213A (es) Derivados de carboxamidas azabiciclicas, su preparacion y su aplicacion en terapeutica
ES2653265T3 (es) Morfinanos sustituidos y el uso de éstos
HN2010001460A (es) Derivados biciclicos de carboxamidas aza-biciclicas, su preparacion y su aplicacion terapeutica
AR093184A1 (es) Compuesto de pirimidina sustituida como inhibidor de quinurenina-3-monooxigenasa y composicion farmaceutica que lo comprenden
BR112013008675A2 (pt) métodos e composições para o tratamento de diabetes e dislipidemia
BR112016006262A2 (pt) composto, composição, material de acabamento automotivo interior ou exterior, artigo agrícola, e, métodos para estabilização de um material orgânico e preparação de um composto
BR112017019439A2 (pt) inibidores kv1.3 e sua aplicação médica
ES2721623T3 (es) Procedimiento novedoso para la preparación de ceftarolina fosamil
MX337320B (es) Análogos halogenados de agentes anti-fibroticos.
CO6400145A2 (es) Derivados de 2-piridin-2-il pirazol-3(2h) -ona, su preparción y su aplicación terapeútica
CO6501157A2 (es) Sales de adición de trometamina con derivados de ácido azabifenilaminobenzoico como inhibidores de dhodh
BR112015006370A2 (pt) meios e métodos para tratamento de tumores sólidos
NI201100115A (es) Derivados de morfina - 6 - glucuronido, su preparación y su aplicación en terapéutica.
AR078094A1 (es) Octasacaridos n-acilos activadores de los receptores de los fgf, su preparacion y su aplicacion en terapeutica
AR085542A1 (es) Compuestos de azaespirodecanona como inhibidores de hsl
BR112017013266A2 (pt) processo para preparação de um composto, composto, e, usos de um composto e de uma dispersão.
CY1116477T1 (el) Μεθοδος εnzυμatiκης συνθεσης toy (7s)-3,4-διμεθοξυδικυκλο[4.2.0] οκτα-1,3,5-τριενo-7-καρβοξυλικου οξεος ή εστερων αυτου και εφαρμογη στην συνθεση της ιβαμπραδινης και των αλατων αυτης
CO6390061A2 (es) Derivados de morfina-6-glucuronido, su preparación y su aplicación en terapeutica
CO6700822A2 (es) Proceso para preparar 3-haloalquilporazoles